World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
129
Citations
72100
World Ranking
241
National Ranking
158

Medicine

D-Index
131
Citations
72906
World Ranking
2374
National Ranking
1338

Overview

Francesco M. Marincola is affiliated with the National Institutes of Health in the United States. The primary focus of their research lies at the intersection of medicine, biochemistry, genetics, and molecular biology, with a notable emphasis on oncology, molecular biology, immunology, genetics, and cancer research.

The scientist's work encompasses a range of topics that include:

  • CAR-T cell therapy research
  • Cancer immunotherapy and biomarkers
  • Immunotherapy and immune responses
  • Virus-based gene therapy research
  • CRISPR and genetic engineering
  • Immune cell function and interaction
  • Colorectal cancer treatments and studies

Francesco M. Marincola has contributed to numerous publications, with frequently appearing venues such as:

  • Journal of Translational Medicine
  • Regular and Young Investigator Award Abstracts
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal for ImmunoTherapy of Cancer
  • Journal of Clinical Oncology

Their recent academic papers reflect ongoing contributions to cancer research and immunotherapy. Notable publications include:

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death (2020), Journal for ImmunoTherapy of Cancer
  • CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances (2023), Molecular Cancer
  • Targeting immunogenic cell stress and death for cancer therapy (2024), Nature Reviews Drug Discovery
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020), Journal of Clinical Oncology
  • Germline genetic contribution to the immune landscape of cancer (2021), Immunity

Collaboration is a key component of Marincola's research environment, reflected by frequent co-authors such as:

  • Davide Bedognetti
  • Alessandra Cesano
  • Jérôme Galon
  • Zhifen Yang
  • Paolo A. Ascierto

Best Publications

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P.S.J. Meltzer;Y.D. Chen;Y. Jiang

  • Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment

    Noriho Iida;Amiran Dzutsev;C. Andrew Stewart;Loretta Smith

  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

    Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu

  • A human memory T cell subset with stem cell-like properties

    Luca Gattinoni;Enrico Lugli;Yun Ji;Zoltan Pos

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.

    Francesco M. Marincola;Elizabeth M. Jaffee;Daniel J. Hicklin;Soldano Ferrone

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors.

    Stephen A. Migueles;M. Shirin Sabbaghian;W. Lesley Shupert;Maria P. Bettinotti

  • gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

    Douglas J. Schwartzentruber;David H. Lawson;Jon M. Richards;Robert M. Conry

  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death

    Lorenzo Galluzzi;Ilio Vitale;Sarah Warren;Sandy Adjemian

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures

    Jérôme Galon;Helen K. Angell;Helen K. Angell;Helen K. Angell;Davide Bedognetti;Francesco M. Marincola;Francesco M. Marincola

  • The role of BRAF V600 mutation in melanoma

    Paolo A. Ascierto;John M. Kirkwood;Jean Jacques Grob;Ester Simeone

  • High-fidelity mRNA amplification for gene profiling.

    Ena Wang;Lance D. Miller;Galen A. Ohnmacht;Edison T. Liu

  • Phase I Study of the Intravenous Administration of Attenuated Salmonella typhimurium to Patients With Metastatic Melanoma

    John F. Toso;Vee J. Gill;Patrick Hwu;Francesco M. Marincola

  • Tumour immunity: effector response to tumour and role of the microenvironment.

    Alberto Mantovani;Pedro Romero;A Karolina Palucka;Francesco M Marincola

  • Loss of HLA class I antigens by melanoma cells: molecular mechanisms, functional significance and clinical relevance.

    Soldano Ferrone;Francesco M. Marincola

  • Loss of Functional Beta2-Microglobulin in Metastatic Melanomas From Five Patients Receiving Immunotherapy

    Nicholas P. Restifo;Francesco M. Marincola;Yutaka Kawakami;Jeff Taubenberger

  • The dual role of IL-10

    Simone Mocellin;Monica C Panelli;Ena Wang;Dirk Nagorsen

  • The immune score as a new possible approach for the classification of cancer

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Magdalena Thurin

  • Molecular classification of cutaneous malignant melanoma by gene expression profiling

    M. Bittner;P. Meltzer;Y. Chen;Y. Jiang

Frequent Co-Authors

Ena Wang
Ena Wang Toro bio
David F. Stroncek
David F. Stroncek National Institutes of Health
Steven A. Rosenberg
Steven A. Rosenberg National Institutes of Health
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
Licia Rivoltini
Licia Rivoltini Fondazione IRCCS Istituto Nazionale dei Tumori
Soldano Ferrone
Soldano Ferrone Harvard University
Lisa H. Butterfield
Lisa H. Butterfield University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing, for example, offers a pathway to work closely with immunology patients and research. Prospective students might consider online BSN programs for non nurses, which provide an accessible option for individuals without a prior nursing background.

Accelerated paths into nursing are also popular for those seeking faster transitions. The easiest ABSN programs to get into offer streamlined curricula designed to help students quickly gain nursing qualifications and enter clinical settings where immunology expertise is valuable.

Additionally, Licensed Practical Nurse (LPN) programs serve as an entry point into healthcare roles. Identifying which LPN programs are easiest to get into can aid applicants in selecting schools that match their academic and scheduling needs without compromising quality education.

For those aiming to advance further, nurse practitioner degrees offer advanced clinical roles. Many consider the easiest online nurse practitioner programs to balance career progression with flexibility, often focusing on specialties connected to immunological health conditions.

Best Scientists Citing Francesco M. Marincola

Trending Scientists